7BPY
X-ray structure of human PPARalpha ligand binding domain-clofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-17A |
Synchrotron site | Photon Factory |
Beamline | BL-17A |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-03-07 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1.00000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 60.535, 101.646, 61.425 |
Unit cell angles | 90.00, 101.82, 90.00 |
Refinement procedure
Resolution | 38.576 - 2.090 |
R-factor | 0.1943 |
Rwork | 0.193 |
R-free | 0.21550 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3sp6 |
RMSD bond length | 0.005 |
RMSD bond angle | 0.704 |
Data reduction software | XDS |
Data scaling software | Aimless (0.5.21) |
Phasing software | PHASER (2.7.16) |
Refinement software | PHENIX (1.11.1-2575-000) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 47.320 | 47.320 | 2.150 |
High resolution limit [Å] | 2.090 | 9.110 | 2.090 |
Rmerge | 0.042 | 0.013 | 0.344 |
Rmeas | 0.049 | 0.016 | 0.404 |
Rpim | 0.026 | 0.008 | 0.211 |
Number of reflections | 42307 | 521 | 3279 |
<I/σ(I)> | 19.3 | 4 | |
Completeness [%] | 98.3 | 95.9 | 97.6 |
Redundancy | 3.5 | 3.4 | 3.6 |
CC(1/2) | 0.999 | 1.000 | 0.899 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 277 | 0.1 M Tris (pH 8.5), 30 %(w/v) PEG3350 |